Skip to content
Screener

Oruka Therapeutics, Inc. ORKA Current Liabilities Assumed in Business Combination

Current Liabilities Assumed in Business Combination at other companies

Arthur J. Gallagher logo
Arthur J. GallagherAJG
$20M
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
$12.59M
Coda Octopus Group, Inc. logo
Coda Octopus Group, Inc.CODA
$394.93K-4.4%
CBA
CBAK Energy Technology, Inc.CBAT
$333.82K
RBC Bearings logo
RBC BearingsRBC
$34.8M
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$84M

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$6.34B+1,198%
Enterprise value$6.29B+1,379%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities.

The source filing: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026.

Filed
Mar 12, 2026, 4:03 PM EDT
Fiscal year
FY2025
Accession
0001213900-26-026929
Cash and cash equivalents$4,940
Other current assets114
Accrued liabilities(54)
Net assets acquired$5,000

Item 8. Financial Statements and Supplementary

FAQ

What is Oruka Therapeutics, Inc.'s current liabilities assumed in business combination?
Oruka Therapeutics, Inc. (ORKA) reported current liabilities assumed in business combination of $54K in Q3 2024.
What does current liabilities assumed in business combination mean?
This represents the current obligations and liabilities taken on by the company as a result of a business combination or acquisition. Monitoring this figure is essential for assessing the short-term debt burden and operational commitments inherited from acquired entities.

Ask your AI about Oruka Therapeutics, Inc.'s current liabilities assumed in business combination.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude